Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

ASAN FOUNDATION

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Private

Established: 1989-06-23

Employees: 501

Market Cap: -

Website: https://ails.amc.seoul.kr

Clinical Trials

Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon Cancer

Phase 2

Completed

Conditions: Metastatic Colorectal Cancer

Interventions: Drug: Bevacizumab

First Posted Date: 2006-09-19

Last Posted Date: 2013-01-23

Lead Sponsor: Asan Medical Center

Target Recruit Count: 49

Registration Number: NCT00378066

Locations: 🇰🇷
National Cancer Center, Goyang, Korea, Republic of
🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

and more 3 locations

Gemcitabine for Marginal Zone Lymphoma

Phase 2

Terminated

Conditions: Non-Hodgkin's Lymphoma
Marginal Zone Lymphoma

Interventions: Drug: gemcitabine

First Posted Date: 2006-06-15

Last Posted Date: 2016-02-17

Lead Sponsor: Asan Medical Center

Target Recruit Count: 43

Registration Number: NCT00337259

Locations: 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin as 2nd Line Therapy for Non-Hodgkin's Lymphoma (NHL)

Phase 2

Completed

Conditions: Non-Hodgkin's Lymphoma

Interventions: Drug: Oxaliplatin

First Posted Date: 2006-06-14

Last Posted Date: 2018-06-26

Lead Sponsor: Asan Medical Center

Target Recruit Count: 27

Registration Number: NCT00336583

Locations: 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

Zevalin Plus BuCyE High-dose Therapy in B-cell Non-Hodgkin's Lymphoma

Phase 2

Completed

Conditions: Non-Hodgkin's Lymphoma

Interventions: Drug: Zevalin-BuCyE

First Posted Date: 2006-06-14

Last Posted Date: 2016-02-17

Lead Sponsor: Asan Medical Center

Target Recruit Count: 19

Registration Number: NCT00336843

Locations: 🇰🇷
Asan Medical Center, Departement of Internal Medicine, Division of Oncology, Seoul, Korea, Republic of

Efficacy and Safety of Intravitreal Triamcinolone Acetonide in Eyes With Post Vitrectomy Diabetic Vitreous Hemorrhage

Not Applicable

Conditions: Post Vitrectomy State
Recurrent Diabetic Vitreous Hemorrhage

First Posted Date: 2006-03-08

Last Posted Date: 2007-06-13

Lead Sponsor: Asan Medical Center

Target Recruit Count: 30

Registration Number: NCT00300014

Locations: 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

Trial of Adjuvant Chemotherapy for Gastric Cancer

Phase 3

Completed

Conditions: Stomach Cancer

Interventions: Drug: cisplatin, mitomycin-C, doxifluridine

First Posted Date: 2006-02-27

Last Posted Date: 2020-01-18

Lead Sponsor: Asan Medical Center

Target Recruit Count: 528

Registration Number: NCT00296322

Locations: 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

Trial of Adjuvant Chemotherapy for Gastric Cancer

Phase 3

Completed

Conditions: Stomach Cancer

Interventions: Drug: Mitomycin and doxifluridine
Drug: Mitomycin, doxifluridine and cisplatin

First Posted Date: 2006-02-27

Last Posted Date: 2014-02-27

Lead Sponsor: Asan Medical Center

Target Recruit Count: 855

Registration Number: NCT00296335

Locations: 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

Capecitabine Versus S-1 in Elderly Advanced Gastric Cancer (AGC): Randomized Trial

Phase 2

Completed

Conditions: Gastric Cancer

Interventions: Drug: Capecitabine
Drug: S-1

First Posted Date: 2006-01-19

Last Posted Date: 2014-02-25

Lead Sponsor: Asan Medical Center

Target Recruit Count: 96

Registration Number: NCT00278863

Locations: 🇰🇷
National Cancer Center, Goyang, Gyeonggi-do, Korea, Republic of
🇰🇷
Hallym University Sacred Heart Hospital, Pyeongchon, Gyeonggido, Korea, Republic of
🇰🇷
Kyung Pook National University Hospital, Daegu, Korea, Republic of

and more 6 locations

Adjuvant Imatinib in High-risk Gastrointestinal Stromal Tumor (GIST) With C-kit Mutation

Phase 2

Completed

Conditions: Gastrointestinal Stromal Tumors
Sarcoma

Interventions: Drug: Imatinib mesylate (Glivec)

First Posted Date: 2006-01-19

Last Posted Date: 2020-01-07

Lead Sponsor: Asan Medical Center

Target Recruit Count: 47

Registration Number: NCT00278876

Locations: 🇰🇷
National Cancer Center, Goyang, Korea, Republic of
🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of

and more 1 locations

Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II

Phase 4

Completed

Conditions: Cerebral Infarction
Atherosclerosis

Interventions: Drug: Cilostazol
Drug: clopidogrel

First Posted Date: 2005-08-15

Last Posted Date: 2010-01-12

Lead Sponsor: Asan Medical Center

Target Recruit Count: 457

Registration Number: NCT00130039

Locations: 🇭🇰
Prince of Wales Hospital, Hong Kong, Hong Kong
🇭🇰
Queen Mary Hospital, Hong Kong, Hong Kong
🇰🇷
Konkuk Univ. Hospital, Seoul, Gwangjin-gu Hwayang-dong, Korea, Republic of

and more 16 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy